Iqvia Holdings Inc. (IQV)
Sector: Industrials
Industry: Services-Commercial Physical & Biological Research
Country: United States
Exchange: NYSE
Market cap: $44.35B
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Latest financial period: March 31, 2026
Filed with the SEC: May 5, 2026
Estimated earnings date: October 27, 2026
Profit #751 of 1484 companies
| | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|
| ROIC | 9.6% | 9.6% | 9.7% | 9.7% |
Growth #1024 of 1484 companies
Payout #488 of 1484 companies
Safety #639 of 1484 companies
Price #799 of 1484 companies
